Phibro Animal Health Corporation - Class A Common Stock (PAHC)
38.40
+6.20 (19.24%)
NASDAQ · Last Trade: Aug 28th, 1:09 PM EDT
Detailed Quote
Previous Close
32.20
Open
37.91
Bid
38.31
Ask
38.48
Day's Range
33.86 - 38.47
52 Week Range
16.16 - 32.95
Volume
531,659
Market Cap
1.17B
PE Ratio (TTM)
49.22
EPS (TTM)
0.8
Dividend & Yield
0.4800 (1.25%)
1 Month Average Volume
260,624
Chart
About Phibro Animal Health Corporation - Class A Common Stock (PAHC)
Phibro Animal Health Corporation is a global company that focuses on providing a wide range of animal health products and services. It develops, manufactures, and markets products aimed at improving the health and productivity of livestock and poultry, which includes vaccines, diagnostic tools, and nutritional products. By leveraging its expertise in science and technology, the company seeks to enhance animal well-being and optimize food safety and quality throughout the agricultural industry. Additionally, Phibro is committed to innovation and sustainability, striving to meet the evolving needs of farmers and the broader food supply chain. Read More
Phibro shares soared nearly 18% after strong Q4 results beat estimates, driven by growth from the Zoetis MFA acquisition and solid full-year performance.
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2025 and provided its financial guidance for the year ending June 30, 2026.
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time.
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025.
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025.
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 25, 2025, to stockholders of record at the close of business on June 4, 2025.
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time.
